COPART INC (CPRT)

US2172041061 - Common Stock

55.2  +0.8 (+1.47%)

After market: 55.156 -0.04 (-0.08%)

Fundamental Rating

7

Taking everything into account, CPRT scores 7 out of 10 in our fundamental rating. CPRT was compared to 85 industry peers in the Commercial Services & Supplies industry. CPRT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CPRT shows excellent growth, but is valued quite expensive already. These ratings could make CPRT a good candidate for growth and quality investing.



9

1. Profitability

1.1 Basic Checks

In the past year CPRT was profitable.
In the past year CPRT had a positive cash flow from operations.
In the past 5 years CPRT has always been profitable.
Each year in the past 5 years CPRT had a positive operating cash flow.

1.2 Ratios

CPRT has a Return On Assets of 17.85%. This is amongst the best in the industry. CPRT outperforms 98.80% of its industry peers.
Looking at the Return On Equity, with a value of 19.98%, CPRT belongs to the top of the industry, outperforming 87.95% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 18.03%, CPRT belongs to the top of the industry, outperforming 92.77% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CPRT is significantly above the industry average of 10.16%.
Industry RankSector Rank
ROA 17.85%
ROE 19.98%
ROIC 18.03%
ROA(3y)19.81%
ROA(5y)20.58%
ROE(3y)23.59%
ROE(5y)26.43%
ROIC(3y)21.32%
ROIC(5y)22.12%

1.3 Margins

Looking at the Profit Margin, with a value of 33.41%, CPRT belongs to the top of the industry, outperforming 98.80% of the companies in the same industry.
In the last couple of years the Profit Margin of CPRT has grown nicely.
With an excellent Operating Margin value of 39.04%, CPRT belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CPRT has grown nicely.
Looking at the Gross Margin, with a value of 46.23%, CPRT belongs to the top of the industry, outperforming 84.34% of the companies in the same industry.
CPRT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 39.04%
PM (TTM) 33.41%
GM 46.23%
OM growth 3Y1.26%
OM growth 5Y3.45%
PM growth 3Y0.27%
PM growth 5Y6.69%
GM growth 3Y-0.23%
GM growth 5Y1.61%

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CPRT is creating value.
CPRT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CPRT has been increased compared to 5 years ago.
CPRT has a worse debt/assets ratio than last year.

2.2 Solvency

CPRT has an Altman-Z score of 42.08. This indicates that CPRT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 42.08, CPRT belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Debt to FCF ratio of CPRT is 0.00, which is an excellent value as it means it would take CPRT, only 0.00 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.00, CPRT belongs to the top of the industry, outperforming 92.77% of the companies in the same industry.
CPRT has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
CPRT's Debt to Equity ratio of 0.00 is amongst the best of the industry. CPRT outperforms 91.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 42.08
ROIC/WACC1.97
WACC9.14%

2.3 Liquidity

CPRT has a Current Ratio of 7.13. This indicates that CPRT is financially healthy and has no problem in meeting its short term obligations.
CPRT has a better Current ratio (7.13) than 96.39% of its industry peers.
CPRT has a Quick Ratio of 7.04. This indicates that CPRT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 7.04, CPRT belongs to the top of the industry, outperforming 98.80% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.13
Quick Ratio 7.04

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.70% over the past year.
CPRT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.49% yearly.
The Revenue has grown by 10.52% in the past year. This is quite good.
The Revenue has been growing by 16.47% on average over the past years. This is quite good.
EPS 1Y (TTM)20.7%
EPS 3Y-0.65%
EPS 5Y6.49%
EPS growth Q2Q8.2%
Revenue 1Y (TTM)10.52%
Revenue growth 3Y20.61%
Revenue growth 5Y16.47%
Revenue growth Q2Q6.63%

3.2 Future

Based on estimates for the next years, CPRT will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.51% on average per year.
The Revenue is expected to grow by 10.92% on average over the next years. This is quite good.
EPS Next Y16.64%
EPS Next 2Y14.53%
EPS Next 3Y13.21%
EPS Next 5Y11.51%
Revenue Next Year9.82%
Revenue Next 2Y9.36%
Revenue Next 3Y9.73%
Revenue Next 5Y10.92%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 40.29 indicates a quite expensive valuation of CPRT.
Compared to the rest of the industry, the Price/Earnings ratio of CPRT is on the same level as its industry peers.
CPRT's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.73.
Based on the Price/Forward Earnings ratio of 33.40, the valuation of CPRT can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CPRT is on the same level as its industry peers.
CPRT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 20.41.
Industry RankSector Rank
PE 40.29
Fwd PE 33.4

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CPRT is valued a bit more expensive than the industry average as 66.27% of the companies are valued more cheaply.
CPRT's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 61.98
EV/EBITDA 27.92

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of CPRT may justify a higher PE ratio.
CPRT's earnings are expected to grow with 13.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.42
PEG (5Y)6.21
EPS Next 2Y14.53%
EPS Next 3Y13.21%

0

5. Dividend

5.1 Amount

No dividends for CPRT!.
Industry RankSector Rank
Dividend Yield N/A

COPART INC

NASDAQ:CPRT (5/3/2024, 7:00:00 PM)

After market: 55.156 -0.04 (-0.08%)

55.2

+0.8 (+1.47%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap53.07B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 40.29
Fwd PE 33.4
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)2.42
PEG (5Y)6.21
Profitability
Industry RankSector Rank
ROA 17.85%
ROE 19.98%
ROCE
ROIC
ROICexc
ROICexgc
OM 39.04%
PM (TTM) 33.41%
GM 46.23%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 7.13
Quick Ratio 7.04
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)20.7%
EPS 3Y-0.65%
EPS 5Y
EPS growth Q2Q
EPS Next Y16.64%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)10.52%
Revenue growth 3Y20.61%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y